409 related articles for article (PubMed ID: 16060909)
1. High prevalence of differentiated thyroid carcinoma in acromegaly.
Tita P; Ambrosio MR; Scollo C; Carta A; Gangemi P; Bondanelli M; Vigneri R; degli Uberti EC; Pezzino V
Clin Endocrinol (Oxf); 2005 Aug; 63(2):161-7. PubMed ID: 16060909
[TBL] [Abstract][Full Text] [Related]
2. The occurrence of thyroid focal lesions and a need for fine needle aspiration biopsy in patients with acromegaly due to an increased risk of thyroid cancer.
Ruchala M; Skiba A; Gurgul E; Uruski P; Wasko R; Sowinski J
Neuro Endocrinol Lett; 2009; 30(3):382-6. PubMed ID: 19855364
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study.
Gasperi M; Martino E; Manetti L; Arosio M; Porretti S; Faglia G; Mariotti S; Colao AM; Lombardi G; Baldelli R; Camanni F; Liuzzi A;
J Endocrinol Invest; 2002 Mar; 25(3):240-5. PubMed ID: 11936466
[TBL] [Abstract][Full Text] [Related]
4. Goiter and impairment of thyroid function in acromegalic patients: basal evaluation and follow-up.
Cannavò S; Squadrito S; Finocchiaro MD; Curtò L; Almoto B; Vieni A; Trimarchi F
Horm Metab Res; 2000 May; 32(5):190-5. PubMed ID: 10871160
[TBL] [Abstract][Full Text] [Related]
5. [Acromegaly and thyroid disease: prevalence of thyroid cancer].
Marchisotti FG; Umeda LM; Zach PL; Saldanha MD; First OS; Liberman B
Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):843-9. PubMed ID: 16444369
[TBL] [Abstract][Full Text] [Related]
6. Elastosonographic evaluation of thyroid nodules in acromegaly.
Scacchi M; Andrioli M; Carzaniga C; Vitale G; Moro M; Poggi L; Pecori Giraldi F; Fatti LM; Cavagnini F
Eur J Endocrinol; 2009 Oct; 161(4):607-13. PubMed ID: 19666699
[TBL] [Abstract][Full Text] [Related]
7. Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution.
Jallad RS; Musolino NR; Salgado LR; Bronstein MD
Clin Endocrinol (Oxf); 2005 Aug; 63(2):168-75. PubMed ID: 16060910
[TBL] [Abstract][Full Text] [Related]
8. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients.
Dogan S; Atmaca A; Dagdelen S; Erbas B; Erbas T
Endocrine; 2014 Feb; 45(1):114-21. PubMed ID: 23670709
[TBL] [Abstract][Full Text] [Related]
10. Association of primary hyperparathyroidism and non-medullary thyroid cancer.
Krause UC; Friedrich JH; Olbricht T; Metz K
Eur J Surg; 1996 Sep; 162(9):685-9. PubMed ID: 8908448
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of thyroid diseases in patients with acromegaly: experience of a Brazilian center.
Uchoa HB; Lima GA; Corrêa LL; Vidal AP; Cavallieri SA; Vaisman M; Buescu A; Gadelha MR
Arq Bras Endocrinol Metabol; 2013 Dec; 57(9):685-90. PubMed ID: 24402013
[TBL] [Abstract][Full Text] [Related]
12. Detection of colorectal lesions by using autofluorescence colonoscopy in acromegalics and their relation to serum growth hormone and insulin-like growth factor-1 levels.
Matyja V; Kos-Kudla B; Foltyn W; Strzelczyk J; Latos W; Marek B; Kajdaniuk D; Karpe J; Ostrowska Z; Sieron-Stoltny K; Sieron A
Neuro Endocrinol Lett; 2006 Oct; 27(5):639-43. PubMed ID: 17159821
[TBL] [Abstract][Full Text] [Related]
13. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
14. Risk of colorectal neoplasm in patients with acromegaly and its relationship with serum growth hormone levels.
Matano Y; Okada T; Suzuki A; Yoneda T; Takeda Y; Mabuchi H
Am J Gastroenterol; 2005 May; 100(5):1154-60. PubMed ID: 15842593
[TBL] [Abstract][Full Text] [Related]
15. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
16. When fine-needle aspiration biopsy cannot exclude papillary thyroid cancer: a therapeutic dilemma.
Mittendorf EA; Khiyami A; McHenry CR
Arch Surg; 2006 Oct; 141(10):961-6; discussion 966. PubMed ID: 17043273
[TBL] [Abstract][Full Text] [Related]
17. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role.
Fiore E; Rago T; Provenzale MA; Scutari M; Ugolini C; Basolo F; Di Coscio G; Berti P; Grasso L; Elisei R; Pinchera A; Vitti P
Endocr Relat Cancer; 2009 Dec; 16(4):1251-60. PubMed ID: 19528244
[TBL] [Abstract][Full Text] [Related]
18. Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue?
Jallad RS; Musolino NR; Kodaira S; Cescato VA; Bronstein MD
Clin Endocrinol (Oxf); 2007 Aug; 67(2):310-5. PubMed ID: 17555503
[TBL] [Abstract][Full Text] [Related]
19. [Non-toxic nodular goiter: treatment and follow-up].
Mereu P; Scala M; Schenone F; Schenone G; Comandini D; Gipponi M; Margarino G
Acta Otorhinolaryngol Ital; 1995 Aug; 15(4):301-4. PubMed ID: 8928662
[TBL] [Abstract][Full Text] [Related]
20. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
